ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04390	Hippo signaling pathway	15/87	188/7206	5.13296420173e-09
ko05217	Basal cell carcinoma	9/87	68/7206	9.86450674793e-08
ko04512	ECM-receptor interaction	9/87	79/7206	3.69815773196e-07
ko04550	Signaling pathways regulating pluripotency of stem cells	12/87	165/7206	5.579621961e-07
ko05200	Pathways in cancer	20/87	492/7206	1.06096094661e-06
ko04510	Focal adhesion	13/87	240/7206	5.12128099193e-06
ko05205	Proteoglycans in cancer	13/87	271/7206	1.90745042956e-05
ko05222	Small cell lung cancer	7/87	89/7206	9.06478424279e-05
ko04350	TGF-beta signaling pathway	7/87	103/7206	0.000227472179988
ko05166	HTLV-I infection	11/87	292/7206	0.000719241606718
ko04310	Wnt signaling pathway	8/87	181/7206	0.00146014864182
ko04916	Melanogenesis	7/87	142/7206	0.00156262904301
ko04151	PI3K-Akt signaling pathway	12/87	390/7206	0.00236605771295
ko04391	Hippo signaling pathway - fly	5/87	90/7206	0.00449251519861
ko05224	Breast cancer	7/87	174/7206	0.00488981818714
ko04150	mTOR signaling pathway	7/87	184/7206	0.00660900436763
ko05202	Transcriptional misregulation in cancer	7/87	188/7206	0.0074101342712
ko00830	Retinol metabolism	3/87	42/7206	0.0139024252118
ko04810	Regulation of actin cytoskeleton	8/87	264/7206	0.0140066981724
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	4/87	79/7206	0.0149881077212
ko05144	Malaria	3/87	45/7206	0.0167462725905
ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	2/87	19/7206	0.0215675819407
ko05100	Bacterial invasion of epithelial cells	4/87	99/7206	0.0313563249944
ko05146	Amoebiasis	4/87	99/7206	0.0313563249944
ko05410	Hypertrophic cardiomyopathy (HCM)	4/87	100/7206	0.0323708708049
ko00330	Arginine and proline metabolism	3/87	61/7206	0.0370367068753
ko05414	Dilated cardiomyopathy	4/87	112/7206	0.046047466009